🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey A. Jones

The Ohio State University

ORCID: 0000-0001-9557-0820

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia”.

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

Journal of Clinical Oncology(2020)10.1200/jco.20.00491

N/A

3.8DataRank · unranked

105 citations

Ying Huang, Amy S. Ruppert, Lynne V. Abruzzo, Barbara L. Andersen, Farrukh T. Awan +14 more

Illness representations and psychological outcomes in chronic lymphocytic leukaemia

British Journal of Health Psychology(2021)10.1111/bjhp.12562

N/A

0.474DataRank · unranked

10 citations

Thomas R Valentine, John C. Byrd, Jeffrey A. Jones, Kami J. Maddocks, Jennifer A. Woyach +2 more

Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists

Blood Advances(2020)10.1182/bloodadvances.2020002593

N/A

0DataRank · unranked

23 citations

Ying Huang, Emily Dotson, Shane Sheredy, Seema A. Bhat, John C. Byrd +11 more